2-氨基-5-甲氧基苯甲酰胺 | 1882-71-9

• 物质功能分类: 化学试剂 - 有机试剂 - 酰胺
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基-5-甲氧基苯甲酰胺
• 中文别名: 一缩二乙二醇一(2-乙基已基)醚；二甘醇(2-乙己基)醚；2-乙己基卡必醇；二甘醇一(2-乙己基)醚；二乙二醇单辛醚；一缩二乙二醇单(2-乙基已基)醚；2-{(2-[(2-乙基己基)氧基]乙氧基}乙醇；二甘醇单(2-乙己基)醚
• 英文名称: 2-amino-5-methoxybenzamide
• 英文别名: 5-methoxy-2-aminobenzamide；2-Amino-5-methoxy-benzamid
• CAS: 1882-71-9
• 化学式: C₈H₁₀N₂O₂
• 分子量: 166.18
• InChiKey: NWZIAOBMRQYTTD-UHFFFAOYSA-N

物化性质

• 熔点：
  157-158 °C
• 沸点：
  294.4±25.0 °C(Predicted)
• 密度：
  1.236±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  78.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2924299090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-5-methoxybenzamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-5-methoxybenzamide
CAS number: 1882-71-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H10N2O2
Molecular weight: 166.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-5-甲氧基苯甲酰胺 在 氢氧化钾 作用下， 生成 2-氨基-5-甲氧基苯甲酸
  参考文献：
  名称：

  SANDMEYER REACTIONS OF MONOACYL ARYLENEDIAMINES

  摘要：

  DOI：

  10.1021/jo01364a008
• 作为产物：
  描述：

  5-甲氧基-2-硝基苯甲酸 在 吡啶 、 盐酸 、 氯化亚砜 、 氨 、 tin(ll) chloride 作用下， 以 氯仿 、 水 为溶剂， 生成 2-氨基-5-甲氧基苯甲酰胺
  参考文献：
  名称：

  基于蒽酰胺的2-苯基环丙烷-1-羧酰胺，1,1'-联苯-4-羧酰胺和1,1'-联苯-2-羧酰胺：合成生物学评估和作用机理。

  摘要：

  通过从以下步骤开始的多步方法，获得了几种基于蒽酰胺的2-苯基环丙烷-1-羧酰胺13a-f，1,1'-联苯基-4-羧酰胺14a-f和1,1'-联苯基-2-羧酰胺17a-f。 （1S，2S）-2-苯基环丙烷-1-羰基氯11、1,1'-联苯基-4-羰基氯12或1,1'-联苯基-2-羰基氯16与适当的邻氨基苯甲酰胺衍生物10a -F。衍生物13a-f，14a-f和17a-f对人白血病K562细胞具有抗增殖活性。在这些衍生物中，13b，14b和17b对肿瘤细胞具有特殊的细胞毒性作用。衍生物17b对K562细胞显示出比13b和14b更好的抗肿瘤作用。为探索17b作用方式而进行的分析表明，它诱导了细胞周期的G2 / M期停滞，这是DNA损伤的结果，磷酸化ATM和γH2AX是DNA修复反应系统的两个已知标志物的增加证明了这一点。17b的作用还与ROS的产生，JNK的活化和caspase-3依赖性细胞凋亡的诱导有关。

  DOI：

  10.1016/j.ejmech.2017.03.051
• 作为试剂：
  描述：

  6-硝基胡椒醛 、 Cornforth reagent 在 水 、 乙酸乙酯 、 magnesium sulfate 、 2-氨基-5-甲氧基苯甲酰胺 作用下， 反应 4.0h， 以to afford 16 (0.7 g) as brown powder的产率得到6-aminobenzo[d][1,3]dioxole-5-carboxamide
  参考文献：
  名称：

  2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions

  摘要：

  合成了两系列6,7,2′,3′,4′,5′-取代的2-苯基-4-喹唑啉酮和6,2′,3′,4′,5′-取代的2,3-二氢-2-苯基-4-喹唑啉酮，并对它们进行了细胞毒性评估，针对人类肿瘤细胞系，如鼻咽癌表皮样癌（KB）、肺癌（A-549）、回肠癌（HCT-8）、乳腺癌（MCF-7）、黑色素瘤（SKMEL-2）、卵巢癌（1A9）、胶质母细胞瘤（U-87-MG）、骨癌（HOS）、表达P-gp的鼻咽癌表皮样癌（KB-VIN）和前列腺癌（PC3）细胞系，其中一些化合物显示出潜在的细胞毒性。本发明还合成了2-苯基-4-烷氧基-喹唑啉化合物，其中一些化合物表现出抗血小板活性。

  公开号：

  US06479499B1

文献信息

• Condensation of anthranilic acids with pyridines to furnish pyridoquinazolones via pyridine dearomatization
  作者：Yajun Yang、Cuiju Zhu、Min Zhang、Shijun Huang、Jingjing Lin、Xiandao Pan、Weiping Su

  DOI：10.1039/c6cc07365d

  日期：——

  The unprecedented carbodiimide-mediated condensation between pyridines and anthranilic acids via pyridines dearomatization at room temperature has been developed to provide a straightforward approach to pyridoquinazolones. The value of this approach...

  已经开发出前所未有的碳二亚胺介导的吡啶与邻氨基苯甲酸之间在室温下经由吡啶脱芳香化作用的缩合反应，从而为吡啶基喹唑酮提供了直接的方法。这种方法的价值...
• Iron nitrate/TEMPO-catalyzed aerobic oxidative synthesis of quinazolinones from alcohols and 2-aminobenzamides with air as the oxidant
  作者：Yongke Hu、Lei Chen、Bindong Li

  DOI：10.1039/c6ra12164k

  日期：——

  A highly efficient, Iron nitrate/TEMPO-catalyzed approach for the synthesis of quinazolinones has been achieved via a one-pot, tandem aerobic oxidative cyclization of primary alcohols with 2-aminobenzamides. This practical reaction tolerates...

  高效，硝酸铁/ TEMPO催化合成喹唑啉酮的方法是通过伯醇与2-氨基苯甲酰胺的一锅串联串联好氧氧化环化反应而实现的。这种实际反应可以容忍...
• Electrochemical oxidative synthesis of 2-benzoylquinazolin-4(3<i>H</i>)-one <i>via</i> C(sp³)–H amination under metal-free conditions
  作者：Yongzhi Hu、Xinhua Ma、Huiqing Hou、Weiming Sun、Shuqing Tu、Mei Wu、Rongkun Lin、Xiuzhi Xu、Fang Ke

  DOI：10.1039/d1cy01230d

  日期：——

  induced C(sp3)–H amination of 2-aminobenzamides with ketones using TBAI as a catalyst was developed, and provided 2-benzoylquinazolin-4(3H)-ones under metal-free conditions. The reaction proceeded using the relatively low-toxicity methanol as the solvent, employed molecular oxygen as the ideal green oxidant in a simple undivided cell, and exhibited high atom economy. The mechanism of this C(sp3)–H amination

  开发了使用 TBAI 作为催化剂的 2-氨基苯甲酰胺与酮的电化学诱导 C(sp 3 )-H 胺化，并在无金属条件下提供了 2-苯甲酰基喹唑啉-4(3 H )-酮。该反应以毒性相对较低的甲醇为溶剂，采用分子氧作为理想的绿色氧化剂，在一个简单的未分体电池中进行，表现出较高的原子经济性。这种 C(sp 3 )-H 胺化策略的机制被认为涉及苯乙酮自由基的产生，并且它很容易进一步氧化形成 2-oxo-2-苯基乙醛。
• COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
  申请人：Wong Norman C.W.

  公开号：US20080188467A1

  公开（公告）日：2008-08-07

  The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.

  本公开涉及化合物，这些化合物可用于调节载脂蛋白A-I（ApoA-I）的表达，以及它们用于治疗和预防心血管疾病及相关疾病状态，包括胆固醇或脂质相关紊乱，例如，动脉粥样硬化。
• Macrocylic Inhibitors of Hepatitis C Virus
  申请人：Simmen Kenneth Alan

  公开号：US20090118312A1

  公开（公告）日：2009-05-07

  Compounds of the formula I: and N-oxides, salts, and stereoisomers thereof wherein A is OR 1 , NHS(═O) p R 2 ; wherein; R 1 is hydrogen, C 1 -C 6 alkyl, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkylene-heterocyclyl; R 2 is C 1 -C 6 alkyl, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkyleneheterocyclyl; p is independently 1 or 2; n is 3, 4, 5 or 6; — denotes an optional double bond; L is N or CRz; Rz is H or forms a double bond with the asterisked carbon; Rq is H or when L is CRz, Rq can also be C 1 -C 6 alkyl; Rr is quinazolinyl, optionally substituted with one two or three substituents each independently selected from C 1 -C 6 alkyl, C 1 -C 6 alkoxy, hydroxyl, halo, haloC 1 -C 6 alkyl, amino, mono- or dialkylamino, mono- or dialkylaminocarbonyl, C 1 -C 6 alkyl-carbonylamino, C 0 -C 3 alkylenecarbocyclyl and C 0 -C 3 alkyleneheterocyclyl; R 5 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxyC 1 -C 6 alkyl or C 3 -C 7 cycloalkyl; R 6 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkylene-heterocyclyl, hydroxy, bromo, chloro or fluoro have utility in the treatment or prophylaxis of flaviviral infections such as HCV

  公式I的化合物： 以及其N-氧化物、盐和立体异构体 其中 A是OR 1 ，NHS(═O) p R 2 ；其中； R 1 是氢、C 1 -C 6 烷基、C 0 -C 3 烷基烯基环烷基、C 0 -C 3 烷基烯基杂环烷基； R 2 是C 1 -C 6 烷基、C 0 -C 3 烷基烯基环烷基、C 0 -C 3 烷基烯基杂环烷基； p独立地为1或2； n为3、4、5或6；— 表示一个可选的双键； L是N或CRz； Rz是H或与带星号的碳形成双键； Rq是H或当L为CRz时，Rq也可以是C 1 -C 6 烷基； Rr是喹唑啉基，可选择地取代一个、两个或三个取代基，每个取代基独立地选自C 1 -C 6 烷基、C 1 -C 6 烷氧基、羟基、卤素、卤代C 1 -C 6 烷基、氨基、单烷基或二烷基氨基、单烷基或二烷基氨基甲酰基、C 1 -C 6 烷基-甲酰氨基、C 0 -C 3 烷基烯基环烷基和C 0 -C 3 烷基烯基杂环烷基； R 5 是氢、C 1 -C 6 烷基、C 1 -C 6 烷氧基C 1 -C 6 烷基或C 3 -C 7 环烷基； R 6 是氢、C 1 -C 6 烷基、C 1 -C 6 烷氧基、C 0 -C 3 烷基烯基环烷基、C 0 -C 3 烷基烯基杂环烷基、羟基、溴、氯或氟在治疗或预防黄病毒感染如HCV中具有用途